A select committee of Britain's House of Lords this week accused the Medicines Control Agency of not dealing with cannabis based medicines in the same impartial manner as it dealt with other medicines. In its report it said that the agency's insistence that new toxicology data were needed on one of the 60 cannabinoids present in raw cannabis would delay the approval of new cannabis based medicines, which patients with severe conditions, such as multiple sclerosis, needed. The select committee on science and technology also deplored the “postcode prosecuting” of people who used …
No takes yet. Share an insight, caveat, or question.
A. Ferriman (2001) studied this question.